{"keywords":["Medullary carcinoma","Multiple endocrine neoplasia type 2","Papillary carcinoma","RET mutation","Thyroid carcinoma"],"meshTags":["Mutation","Adult","Carcinoma, Medullary","Humans","Multiple Endocrine Neoplasia Type 2a","Carcinoma","Comorbidity","Female","Proto-Oncogene Proteins c-ret","Male","Thyroid Neoplasms"],"meshMinor":["Mutation","Adult","Carcinoma, Medullary","Humans","Multiple Endocrine Neoplasia Type 2a","Carcinoma","Comorbidity","Female","Proto-Oncogene Proteins c-ret","Male","Thyroid Neoplasms"],"genes":["V804M","RET proto-oncogene"],"publicationTypes":["Journal Article"],"abstract":"Papillary thyroid carcinoma (PTC) is exceptional in MEN 2.\nThe analysis in 135 patients revealed two PTC, without C-cell pathology; both being positive for V804M mutation (RET proto-oncogene).\nFew data are available about PTC in MEN 2, and without C-cell pathology is even less common. More studies are needed to correlate genetics and histology, and even for assessing PTC as only manifestation of MEN 2.","title":"Papillary thyroid carcinoma and multiple endocrine neoplasia type 2.","pubmedId":"25903693"}